GlassScriptPhysician profile
Carrie Lynn
NPI 1912035064
$7,039.82
in general payments reported to CMS, 2019-2025
36 companies · $1,715 in 2025
The $1,715 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $789 · 2022: $1,073 · 2023: $1,745 · 2024: $1,718 · 2025: $1,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,177.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $816.75 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $805.73 | 2021-2025 | Jardiance |
| Pfizer INC. | $794.94 | 2021-2025 | |
| Aop Health US, LLC | $674.82 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $534.96 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $500.69 | 2021-2025 | Farxiga, Wainua |
| Amgen INC. | $410.54 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $360.84 | 2021-2024 | Xarelto |
| Scpharmaceuticals INC. | $263.40 | 2023-2025 | |
| Amarin Pharma, INC. | $200.02 | 2021-2023 | |
| Medtronic, INC. | $164.02 | 2021-2024 | Symplicity G3 |
| Edwards Lifesciences Corporation | $138.27 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $137.93 | 2022-2024 | Verquvo |
| Abbott Laboratories | $131.23 | 2022-2023 | Mitraclip |
| Lexicon Pharmaceuticals, INC. | $119.85 | 2023-2024 | Inpefa |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $112.17 | 2023-2024 | Opsumit, Uptravi |
| Abiomed | $105.06 | 2022-2024 | Impella |
| Esperion Therapeutics, INC. | $98.95 | 2022-2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $90.57 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $57.52 | 2024 | Arcalyst |
| Novo Nordisk INC | $52.51 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $52.20 | 2021-2023 | |
| Boston Scientific Corporation | $50.52 | 2024 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $47.78 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.65 | 2021-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $35.83 | 2023-2024 | |
| Baxter Healthcare | $32.19 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $29.38 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $29.08 | 2025 | Evkeeza |
| Lantheus Medical Imaging, INC. | $28.71 | 2024 | |
| Stryker Corporation | $26.08 | 2025 | Flowtriever |
| Alnylam Pharmaceuticals INC. | $24.63 | 2025 | |
| Medicomp INC | $22.95 | 2024 | Telepatch Cardiac Monitor |
| Irhythm Technologies, INC. | $17.73 | 2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $16.47 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Lynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.